Please login to the form below

Not currently logged in
Email:
Password:

laquinimod

This page shows the latest laquinimod news and features for those working in and with pharma, biotech and healthcare.

Teva cuts 25% of workforce, with Israel taking a heavy toll

Teva cuts 25% of workforce, with Israel taking a heavy toll

be successor laquinimod and an underperformance in its generic drug operations that have only been amplified by adding the Actavis business.

Latest news

More from news
Approximately 4 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics